Developer docs
API playgroundTry for free, no card

Search company profiles

Planetary

Full company profile

uuid0000dh9

Namestring
Planetary
Legal namestring
Planetary Group AG
Company typeenum
Private
Founded yearint
2022
Descriptiontext

Planetary is a Geneva-based food-technology company founded in 2022 that builds, owns, and operates industrial-scale fermentation facilities to produce sustainable, bio-based ingredients for the food and materials industries. Its core technology is the proprietary BioBlocks fermentation and AI platform, which converts low-value agricultural side streams into high-value proteins, fibers, and enzymes through microbial fermentation. The company operates an industrial-scale 50kL fermentation facility in Aarberg, Switzerland, and sells mycoprotein as a B2B ingredient under the Libre brand for use in plant-based meat and dairy alternatives, alongside bio-based materials such as fossil-free polymers and fibers.

The company's business model combines three revenue streams: B2B ingredient sales of mycoprotein to food manufacturers, contract fermentation manufacturing services at industrial scale, and licensing of the BioBlocks platform to agro-industrial partners, particularly sugar companies, for co-located production using agricultural side streams. Planetary also participates in consumer markets indirectly via the Libre/MyVay consumer brand (post-Libre Foods acquisition), with a nationwide launch through ALDI Suisse across 242 stores in Switzerland at price parity with conventional meat. The company targets ultra-low-cost mycoprotein production below $1 per kilogram and significant environmental gains (>20% GHG, >30% water, >70% farmland savings versus conventional protein production).

Planetary serves food manufacturers seeking alternative protein ingredients, agro-industrial players (sugar companies) seeking to diversify side streams into high-value products, and alternative protein startups needing fermentation capacity. It has raised approximately CHF 32 million in total funding across a 2022 seed round and a 2026 Series A led by Radikal Capital and Oetker Ventures, has received the WIPO Global Award in 2025, and is expanding internationally through the Libre Foods acquisition (Spain) and a licensing partnership with India's DCM Shriram Bioseeds/Dhampur Bio Organics.

Short descriptiontext

Planetary is a Geneva-based food-tech company that builds and operates industrial fermentation facilities to produce sustainable mycoprotein ingredients for food manufacturers, while licensing its proprietary BioBlocks fermentation and AI platform to agro-industrial partners globally.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersGland, Switzerland
HQ citystring
Gland
HQ countrystring
Switzerland
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
precision fermentation, mycoprotein production, alternative protein ingredients, bio-based materials, fermentation technology licensing
Industry2 codes
PRIMARYAFAJAHAE
Mycoprotein & Fungal Proteins (Fusarium/Mycelium-Based)
Agriculture & Food Production/Food Ingredients & Additives/Proteins & Protein Ingredients (Plant/Animal Proteins, Protein Isolates/Concentrates)
SECONDARYAFAJAHAH
Fermentation-Derived Proteins (Precision Fermentation, Biomass Fermentation)
Agriculture & Food Production/Food Ingredients & Additives/Proteins & Protein Ingredients (Plant/Animal Proteins, Protein Isolates/Concentrates)
NAICS code1 code
  • Food Manufacturing311
SIC code2 codes
  • Food And Kindred Products2000
  • Services-Commercial Physical & Biological Research8731
Product category
Industrial Fermentation Services
Social media profiles1 record
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1B2B Mycoprotein Ingredient Sales
TypeTransaction Fee
Description

Sale of mycoprotein as a B2B ingredient under the Libre brand to food manufacturers for use in plant-based meat and dairy alternatives. The company has industrial-scale production operational in Aarberg, Switzerland with active revenue generation.

startupticker.ch
2Technology Licensing
TypeLicensing Royalties
Description

Licensing of proprietary BioBlocks fermentation platform to agro-industrial players, particularly sugar companies, enabling them to convert low-value side streams into high-value proteins. The company targets over 20% cost savings versus conventional protein production.

agfundernews.com
3Contract Manufacturing Services
TypeProfessional Services
Description

Fermentation manufacturing services for external clients, offering production at industrial scale (up to 50kL fermentation units) for bioprocess development, scaling, and finished product production.

agfundernews.com
4Consumer Products
TypeHardware Sales
Description

Sale of consumer products including vegan mycoprotein filet launched nationwide with ALDI Suisse under the MyVay brand, marking entry into direct-to-consumer retail channel.

bioalps.org
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Infrastructure, Personnel, Operations, Marketing or Sales
Pricing details1 tier
1Mycoprotein B2B ingredient pricing
ModelTransaction based/ take rateBilling cadencePay-as-you-go
Notes

Active revenue generation with cost competitiveness aimed at parity with conventional protein sources. No public pricing disclosed.

bioalps.org
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1Libre
Description

B2B mycoprotein ingredient brand sold to food manufacturers for use in meat and dairy alternatives

startupticker.ch
+1 more record
Core offering1 text field

Planetary builds, owns, and operates a global network of industrial fermentation facilities using its proprietary BioBlocks™ fermentation and AI platform to produce sustainable bio-based products at scale. Its core commercial outputs are mycoprotein ingredients (sold under the Libre brand to food manufacturers for plant-based meat and dairy alternatives), bio-based materials (fossil-free polymers, fibers, construction materials), and technology licensing of the BioBlocks™ platform to agro-industrial partners such as sugar companies for co-located production using agricultural side streams.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Over 20% GHG reduction compared to conventional protein production
+4 more records
Product overview1 text field

Planetary operates a full-stack fermentation platform consisting of proprietary BioBlocks™ technology for precision fermentation and AI-driven process optimization. The platform produces mycoprotein ingredients (marketed under Libre brand for B2B and MyVay for consumer products), supports bio-based materials production, and licenses technology to agro-industrial partners. Industrial-scale production is operational in Aarberg, Switzerland, with expansion planned through international licensing deals including India.

Product and service7 records
1Precision Fermentation Platform
CategoryPrecision fermentation services
Description

Full-stack fermentation platform service offering where Planetary builds, owns, and operates a global network of fermentation facilities to produce bio-based products at scale for partners, leveraging proprietary BioBlocks™ fermentation and AI technology.

2BioBlocks™ Fermentation Platform Licensing
CategoryTechnology licensing
Description

Licensing offering that enables agro-industrial partners, particularly sugar companies, to convert low-value agricultural side streams into high-value proteins, fibers, and enzymes through localized co-located production using Planetary's proprietary BioBlocks™ platform. Targets over 20% cost savings versus conventional protein production.

3Mycoprotein Ingredients (Libre Brand)
CategoryAlternative protein ingredients
Description

Whole-food mycoprotein ingredient derived from filamentous fungi (mycelium) for B2B sale to food manufacturers producing plant-based meat and dairy alternatives. Industrial volumes of novel-food approved mycoprotein, naturally high in protein, high in fiber, and low in fat.

4Bio-based Materials
CategoryBio-based materials
Description

Production of fossil-free polymers, fibers, and construction materials using microbial fermentation, with the aim to achieve cost parity with conventional production of sustainable bio-based materials.

5MyVay Gourmet Mycoprotein Filet (Consumer Product)
CategoryConsumer food products
Description

Vegan mycoprotein filet sold under the MyVay brand via ALDI Suisse retail stores in Switzerland, marketed as a clean-label chicken fillet alternative at price parity with conventional meat for end consumers.

6Contract Fermentation Manufacturing Services
CategoryContract manufacturing services
Description

Fermentation manufacturing services for external clients, offering production at industrial scale (up to 50kL fermentation units) for bioprocess development, scaling, and finished product production. Production scale from 300L to 50m3 (50,000 liters).

7Facility Design and Co-location Services
CategoryEngineering and facility services
Description

Planning and design of industrial fermentation facilities with synergistic co-location within industrial settings to share utilities and feedstock for partners deploying BioBlocks™-based production.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-28
Description

Partnership framework to establish mycoprotein production at one of DBO's sugar mills in India. First expansion beyond Aarberg, Switzerland. Licensing of BioBlocks platform for co-located production using agricultural side streams.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-28
Description

Exploring collaboration to produce mycoprotein in India targeting below $1 per kilogram. Partnership aims to unlock ultra-low-cost production leveraging Indian sugar industry infrastructure.

3ALDI Suisse
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-07-18
Description

Launched mycoprotein chicken fillet alternative nationwide in all 242 ALDI Suisse stores under the MyVay brand. Clean-label product at price parity with conventional meat.

bioalps.org
4Libre Foods
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-06-24
Description

Acquired Spanish fungi-based ingredients company Libre Foods to supercharge fungi-based innovation at scale. Includes transfer of assets, know-how, and issuance of financial instruments. GGF advised on the transaction.

bioalps.org
Strategic tierMajorTypeTechnology or IntegrationAnnounced on2024-01-15
Description

Partnership to optimize microbial fermentation through advanced sensors and artificial intelligence. AI-powered optimization for fermentation and food bioprocessing to cut costs of fermented proteins.

Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Precision fermentation leader producing animal-free whey and casein proteins for dairy alternatives. Comparable as a B2B fermentation-derived protein ingredient supplier to food manufacturers, and as a competitor for the same alt-protein R&D and capital ecosystem, though focused on dairy rather than meat.

TypeDirect peer
Description

US mycelium-based meat alternative company producing whole-cut products (MyBacon) from fungal biomass. Direct peer in the mycoprotein/meat alternative category with overlapping end-product positioning (chicken fillet, bacon) and similar B2C retail launch pathway.

TypeEmerging player
Description

Precision fermentation company (formerly Clara Foods) producing animal-free proteins (egg, dairy) via microbial fermentation. Comparable as a precision fermentation B2B ingredient player targeting food manufacturers, with similar technology platform and customer overlap in alternative protein CPGs.

4Culture Biosciences
TypeEmerging player
Description

US fermentation services company offering cloud bioreactors and bioprocess development for industrial customers. Comparable to Planetary's contract manufacturing and bioprocess services arm, with overlapping target customers (synthetic biology, alt-protein developers) seeking fermentation scale-up capacity.

TypeDirect peer
Description

US-based food company producing fungi-based protein (Fy Protein) via proprietary fermentation. Direct peer in mycoprotein/fungal fermentation for alternative protein, with overlapping product positioning (meat and dairy alternatives) and similar B2B and DTC go-to-market.

TypeEmerging player
Description

US fermentation company producing single-cell protein from carbon dioxide via hydrogen-oxidizing bacteria. Comparable as a fermentation-derived protein peer targeting the alternative protein market, with a similar B2B ingredient and sustainable-food value proposition.

TypeBroad incumbent
Description

US-listed cell programming and fermentation platform company that designs and operates microbial manufacturing at scale. Comparable as a horizontal fermentation/biomanufacturing platform with similar end-customers (food, ingredients, industrial biotech) and AI-driven strain/process optimization capabilities.

TypeBroad incumbent
Description

The global mycoprotein incumbent, producing fungi-based protein for meat alternatives. Directly comparable to Planetary on product category (mycoprotein) and end-market (alternative protein), but operates at much larger scale with established global retail distribution and decades of fermentation know-how — making it both Planetary's primary competitive reference and the validation that the category works.

TypeDirect peer
Description

Swedish fermentation company producing mycoprotein (Promyc) for food applications using proprietary fungal biomass processes. Directly comparable as a mycoprotein peer targeting B2B ingredient sales and food-industry applications, with a similar fermentation technology stack and target customer base.

TypeEmerging player
Description

Carbon capture company using gas fermentation to produce fuels and chemicals from industrial emissions. Comparable as a fermentation platform company with a licensing/partnership model for global scale-out, similar tech-stack (proprietary microbial strains + bioreactor processes), and an industrial biotech customer base.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles11 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds5 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors12 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Planetary

Industrial Fermentation Servicesplanetarygroup.ch

Planetary is a Geneva-based food-tech company that builds and operates industrial fermentation facilities to produce sustainable mycoprotein ingredients for food manufacturers, while licensing its proprietary BioBlocks fermentation and AI platform to agro-industrial partners globally.

What Planetary does

Planetary is a Geneva-based food-technology company founded in 2022 that builds, owns, and operates industrial-scale fermentation facilities to produce sustainable, bio-based ingredients for the food and materials industries. Its core technology is the proprietary BioBlocks fermentation and AI platform, which converts low-value agricultural side streams into high-value proteins, fibers, and enzymes through microbial fermentation. The company operates an industrial-scale 50kL fermentation facility in Aarberg, Switzerland, and sells mycoprotein as a B2B ingredient under the Libre brand for use in plant-based meat and dairy alternatives, alongside bio-based materials such as fossil-free polymers and fibers.

The company's business model combines three revenue streams: B2B ingredient sales of mycoprotein to food manufacturers, contract fermentation manufacturing services at industrial scale, and licensing of the BioBlocks platform to agro-industrial partners, particularly sugar companies, for co-located production using agricultural side streams. Planetary also participates in consumer markets indirectly via the Libre/MyVay consumer brand (post-Libre Foods acquisition), with a nationwide launch through ALDI Suisse across 242 stores in Switzerland at price parity with conventional meat. The company targets ultra-low-cost mycoprotein production below $1 per kilogram and significant environmental gains (>20% GHG, >30% water, >70% farmland savings versus conventional protein production).

Planetary serves food manufacturers seeking alternative protein ingredients, agro-industrial players (sugar companies) seeking to diversify side streams into high-value products, and alternative protein startups needing fermentation capacity. It has raised approximately CHF 32 million in total funding across a 2022 seed round and a 2026 Series A led by Radikal Capital and Oetker Ventures, has received the WIPO Global Award in 2025, and is expanding internationally through the Libre Foods acquisition (Spain) and a licensing partnership with India's DCM Shriram Bioseeds/Dhampur Bio Organics.

Planetary firmographics

Firmographics
Name
Planetary
Legal name
Planetary Group AG
Website
https://planetarygroup.ch
Company type
Private
Founded year
2022
Operating status
Operating
Headcount range
11–50 employees
Short description
Planetary is a Geneva-based food-tech company that builds and operates industrial fermentation facilities to produce sustainable mycoprotein ingredients for food manufacturers, while licensing its proprietary BioBlocks fermentation and AI platform to agro-industrial partners globally.
Ownership category
akta.pro rank

Planetary industry classification

Industry
Product category
Industrial Fermentation Services
NAICS
Food Manufacturing (311)
SIC
Food And Kindred Products (2000), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYAFAJAHAE
Mycoprotein & Fungal Proteins (Fusarium/Mycelium-Based)
Agriculture & Food Production/Food Ingredients & Additives/Proteins & Protein Ingredients (Plant/Animal Proteins, Protein Isolates/Concentrates)
SECONDARYAFAJAHAH
Fermentation-Derived Proteins (Precision Fermentation, Biomass Fermentation)
Agriculture & Food Production/Food Ingredients & Additives/Proteins & Protein Ingredients (Plant/Animal Proteins, Protein Isolates/Concentrates)

Keywords

  • Precision fermentation
  • Mycoprotein production
  • Alternative protein ingredients
  • Bio-based materials
  • Fermentation technology licensing

Where Planetary is headquartered

Location

Headquarters

HQ city
Gland
HQ country
Switzerland
HQ region
Europe

Offices3 records

Markets served

Planetary business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Infrastructure, Personnel, Operations, Marketing or Sales

Revenue model

  1. B2B Mycoprotein Ingredient Sales: Sale of mycoprotein as a B2B ingredient under the Libre brand to food manufacturers for use in plant-based meat and dairy alternatives. The company has industrial-scale production operational in Aarberg, Switzerland with active revenue generation.
  2. Technology Licensing: Licensing of proprietary BioBlocks fermentation platform to agro-industrial players, particularly sugar companies, enabling them to convert low-value side streams into high-value proteins. The company targets over 20% cost savings versus conventional protein production.
  3. Contract Manufacturing Services: Fermentation manufacturing services for external clients, offering production at industrial scale (up to 50kL fermentation units) for bioprocess development, scaling, and finished product production.
  4. Consumer Products: Sale of consumer products including vegan mycoprotein filet launched nationwide with ALDI Suisse under the MyVay brand, marking entry into direct-to-consumer retail channel.

Pricing tiers

ModelBillingPrice
Transaction based/ take ratePay-as-you-goMycoprotein B2B ingredient pricing

Go-to-market motion3 records

Distribution channels3 records

Marketing channels3 records

Planetary product offering

Product offering

Core offering

Planetary builds, owns, and operates a global network of industrial fermentation facilities using its proprietary BioBlocks™ fermentation and AI platform to produce sustainable bio-based products at scale. Its core commercial outputs are mycoprotein ingredients (sold under the Libre brand to food manufacturers for plant-based meat and dairy alternatives), bio-based materials (fossil-free polymers, fibers, construction materials), and technology licensing of the BioBlocks™ platform to agro-industrial partners such as sugar companies for co-located production using agricultural side streams.

Product overview

Planetary operates a full-stack fermentation platform consisting of proprietary BioBlocks™ technology for precision fermentation and AI-driven process optimization. The platform produces mycoprotein ingredients (marketed under Libre brand for B2B and MyVay for consumer products), supports bio-based materials production, and licenses technology to agro-industrial partners. Industrial-scale production is operational in Aarberg, Switzerland, with expansion planned through international licensing deals including India.

Differentiator

Problem solved

Functional benefit

Brands

  • Libre: B2B mycoprotein ingredient brand sold to food manufacturers for use in meat and dairy alternatives
  • MyVay

Products and services

  • Precision Fermentation Platform Full-stack fermentation platform service offering where Planetary builds, owns, and operates a global network of fermentation facilities to produce bio-based products at scale for partners, leveraging proprietary BioBlocks™ fermentation and AI technology.
  • BioBlocks™ Fermentation Platform Licensing Licensing offering that enables agro-industrial partners, particularly sugar companies, to convert low-value agricultural side streams into high-value proteins, fibers, and enzymes through localized co-located production using Planetary's proprietary BioBlocks™ platform. Targets over 20% cost savings versus conventional protein production.
  • Mycoprotein Ingredients (Libre Brand) Whole-food mycoprotein ingredient derived from filamentous fungi (mycelium) for B2B sale to food manufacturers producing plant-based meat and dairy alternatives. Industrial volumes of novel-food approved mycoprotein, naturally high in protein, high in fiber, and low in fat.
  • Bio-based Materials Production of fossil-free polymers, fibers, and construction materials using microbial fermentation, with the aim to achieve cost parity with conventional production of sustainable bio-based materials.
  • MyVay Gourmet Mycoprotein Filet (Consumer Product) Vegan mycoprotein filet sold under the MyVay brand via ALDI Suisse retail stores in Switzerland, marketed as a clean-label chicken fillet alternative at price parity with conventional meat for end consumers.
  • Contract Fermentation Manufacturing Services Fermentation manufacturing services for external clients, offering production at industrial scale (up to 50kL fermentation units) for bioprocess development, scaling, and finished product production. Production scale from 300L to 50m3 (50,000 liters).
  • Facility Design and Co-location Services Planning and design of industrial fermentation facilities with synergistic co-location within industrial settings to share utilities and feedstock for partners deploying BioBlocks™-based production.

Quantifiable outcome

  • Over 20% GHG reduction compared to conventional protein production
  • +4 more outcomes

Companies that use Planetary

Customer profile

Named customers1 record

Segments4 records

Ideal customer profiles3 records

Planetary technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature4 records

Planetary partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core and major.

  • DCM Shriram Bioseeds (DBO)coreStrategic or Co-development Partner · 28 January 2026Partnership framework to establish mycoprotein production at one of DBO's sugar mills in India. First expansion beyond Aarberg, Switzerland. Licensing of BioBlocks platform for co-located production using agricultural side streams.
  • Dhampur Bio OrganicscoreStrategic or Co-development Partner · 28 January 2026Exploring collaboration to produce mycoprotein in India targeting below $1 per kilogram. Partnership aims to unlock ultra-low-cost production leveraging Indian sugar industry infrastructure.
  • ALDI SuissecoreChannel Partner/ Reseller/ Distributor · 18 July 2025Launched mycoprotein chicken fillet alternative nationwide in all 242 ALDI Suisse stores under the MyVay brand. Clean-label product at price parity with conventional meat.
  • Libre FoodscoreStrategic or Co-development Partner · 24 June 2025Acquired Spanish fungi-based ingredients company Libre Foods to supercharge fungi-based innovation at scale. Includes transfer of assets, know-how, and issuance of financial instruments. GGF advised on the transaction.
  • Konica MinoltamajorTechnology or Integration · 15 January 2024Partnership to optimize microbial fermentation through advanced sensors and artificial intelligence. AI-powered optimization for fermentation and food bioprocessing to cut costs of fermented proteins.

Scale indicators6 records

Recent moves9 records

Expansion highlights7 records

Planetary competitors and assessment

Company assessment

Broad incumbents

  • Perfect Day: Precision fermentation leader producing animal-free whey and casein proteins for dairy alternatives. Comparable as a B2B fermentation-derived protein ingredient supplier to food manufacturers, and as a competitor for the same alt-protein R&D and capital ecosystem, though focused on dairy rather than meat.
  • Ginkgo Bioworks: US-listed cell programming and fermentation platform company that designs and operates microbial manufacturing at scale. Comparable as a horizontal fermentation/biomanufacturing platform with similar end-customers (food, ingredients, industrial biotech) and AI-driven strain/process optimization capabilities.
  • Quorn Foods: The global mycoprotein incumbent, producing fungi-based protein for meat alternatives. Directly comparable to Planetary on product category (mycoprotein) and end-market (alternative protein), but operates at much larger scale with established global retail distribution and decades of fermentation know-how — making it both Planetary's primary competitive reference and the validation that the category works.

Direct peers

  • MyForest Foods: US mycelium-based meat alternative company producing whole-cut products (MyBacon) from fungal biomass. Direct peer in the mycoprotein/meat alternative category with overlapping end-product positioning (chicken fillet, bacon) and similar B2C retail launch pathway.
  • Nature's Fynd: US-based food company producing fungi-based protein (Fy Protein) via proprietary fermentation. Direct peer in mycoprotein/fungal fermentation for alternative protein, with overlapping product positioning (meat and dairy alternatives) and similar B2B and DTC go-to-market.
  • Mycorena: Swedish fermentation company producing mycoprotein (Promyc) for food applications using proprietary fungal biomass processes. Directly comparable as a mycoprotein peer targeting B2B ingredient sales and food-industry applications, with a similar fermentation technology stack and target customer base.

Emerging players

  • The EVERY Company: Precision fermentation company (formerly Clara Foods) producing animal-free proteins (egg, dairy) via microbial fermentation. Comparable as a precision fermentation B2B ingredient player targeting food manufacturers, with similar technology platform and customer overlap in alternative protein CPGs.
  • Culture Biosciences: US fermentation services company offering cloud bioreactors and bioprocess development for industrial customers. Comparable to Planetary's contract manufacturing and bioprocess services arm, with overlapping target customers (synthetic biology, alt-protein developers) seeking fermentation scale-up capacity.
  • Air Protein: US fermentation company producing single-cell protein from carbon dioxide via hydrogen-oxidizing bacteria. Comparable as a fermentation-derived protein peer targeting the alternative protein market, with a similar B2B ingredient and sustainable-food value proposition.
  • LanzaTech: Carbon capture company using gas fermentation to produce fuels and chemicals from industrial emissions. Comparable as a fermentation platform company with a licensing/partnership model for global scale-out, similar tech-stack (proprietary microbial strains + bioreactor processes), and an industrial biotech customer base.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Planetary social profiles

Digital presence

Planetary financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Planetary leadership team

Management profile

Number of profiles

Profiles11 records

Planetary subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Planetary funding detail

Funding detail

Funding overview

Funding rounds5 records

Investors12 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Planetary M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Planetary

What does Planetary do?

Planetary builds, owns, and operates a global network of industrial fermentation facilities using its proprietary BioBlocks™ fermentation and AI platform to produce sustainable bio-based products at scale. Its core commercial outputs are mycoprotein ingredients (sold under the Libre brand to food manufacturers for plant-based meat and dairy alternatives), bio-based materials (fossil-free polymers, fibers, construction materials), and technology licensing of the BioBlocks™ platform to agro-industrial partners such as sugar companies for co-located production using agricultural side streams.

Is Planetary a public or private company?

Planetary is a private company. It is classified as venture growth investor backed and is currently operating.

When was Planetary founded?

Planetary was founded in 2022. It employs 11 to 50 people.

Where is Planetary based?

Planetary is headquartered in Gland, Switzerland, in the Europe region.

How does Planetary make money?

Four revenue lines are on record. B2B Mycoprotein Ingredient Sales are the primary driver. The others are technology Licensing, contract Manufacturing Services and consumer Products.

Who are Planetary's main competitors?

Broad incumbents on record are Perfect Day, Ginkgo Bioworks and Quorn Foods. Direct peers are MyForest Foods, Nature's Fynd and Mycorena. Emerging players are The EVERY Company, Culture Biosciences, Air Protein and LanzaTech.

Does Planetary have an API?

No public API is recorded for Planetary.

What industry is Planetary in?

Planetary's product category is Industrial Fermentation Services. Its primary akta.pro industry code is AFAJAHAE, Mycoprotein & Fungal Proteins (Fusarium/Mycelium-Based), with a secondary code of AFAJAHAH, Fermentation-Derived Proteins (Precision Fermentation, Biomass Fermentation). Its NAICS code is 311 and its SIC code is 2000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
ScanXDhampur Bio signs exclusive mycoprotein licensing deal with Planetary SADhampur Bio signed an exclusive mycoprotein licensing deal with Planetary SA on October 19, 2026, granting it production rights in India. The agreement includes a 10% royalty on after-tax revenue paid quarterly and a joint venture for commercialization. Sugar and molasses will serve as feedstock for the new product line.LinkedInThe Good Food InstituteThis article summarizes three developments in the alternative protein sector: Illinois State Senator Mattie Hunter's op-ed advocating for protein innovation investment to strengthen regional food security, fermentation company Planetary raising $28 million to expand shared manufacturing infrastructure, and Ajinomoto Co., Inc. developing a plant-based transferrin as a cost-reduction breakthrough for cultivated meat production.FoodHack🏆 And the winner is...Kioga won the 2026 FoodTech World Cup at HackSummit, with its CEO citing a shift toward biology-first food solutions. The roundup also covers 48 AgriFoodTech unicorns, novel food approvals, and funding rounds, including Cosaic's $6M seed extension and Afresh's $34M raise.Pulse 2.0Planetary: $28 Million Raise To Scale Fermentation Platform For Sustainable Protein And IngredientsPlanetary raised $28 million in combined equity and credit financing led by Radikal Capital and Oetker Ventures to expand its global fermentation platform for sustainable protein and food ingredients. The funding brings the company's total capital raised to nearly $40 million and will support its licensing model for localized production and expansion of B2B mycoprotein products under the Libre brand across Europe. The company has already established industrial-scale production in Aarberg, Switzerland, with active revenue generation and cost competitiveness aimed at parity with conventional protein sources.Swiss Food & Nutrition Valleyplanetary raises ~$28 million (CHF 22 million) in funding to scale global fermentation infrastructure and licensing platformPlanetary SA raised about $20 million in equity and $7.5 million in credit, bringing total funding to roughly $40 million. The round was led by Radikal Capital and Oetker Ventures, supporting its fermentation technology licensing and global ingredient rollout. The company plans a second closing later this summer.AgFunderNewsPlanetary nets $28m to scale fermentation infrastructure and licensing platformSwiss startup Planetary has raised CHF 16 million ($20 million) in Series A equity financing supplemented by CHF 6 million ($7.5 million) in credit to scale its fermentation infrastructure and licensing platform. The round was led by Radikal Capital and Oetker Ventures with participation from multiple investors including Astanor Ventures, Royal Cosun, and Green Generation Fund. The company supplies mycoprotein as a B2B ingredient under the Libre brand and is exploring a collaboration with Dhampur Bio Organics to produce mycoprotein in India at below $1 per kilogram.EU-StartupsSwiss startup Planetary raises nearly €23 million to build the industrial backbone of the bioeconomyPlanetary, a Swiss full-stack fermentation company, has raised nearly €23 million in Series A equity financing (€17 million) and credit (€6.3 million), bringing its total funding to approximately €34 million. The round was led by Radikal Capital and Oetker Ventures, with participation from investors including Royal Cosun, arc investors, Green Generation Fund, AgriFoodTech Venture Alliance, Astanor Ventures, and XAnge. The company plans to use the funding to fuel its global ingredient commercial rollout and technology licensing strategy, with industrial-scale production already operational in Aarberg, Switzerland and collaborations targeting ultra-low-cost mycoprotein production below €0.85/kg.BioAlpsplanetary Raises CHF 16 Million to Advance Microprotein ProductionPlanetary, a Geneva-based fermentation startup, raised CHF 16 million in a Series A round led by Radikal Capital and Oetker Ventures, plus CHF 6 million in credit. The funding will expand fermentation infrastructure and its licensing platform. The company plans a second closing later this summer.TechStartupsTop Startup and Tech Funding News – April 20 2025On April 20, 2026, multiple startups raised capital across AI, robotics, healthcare, and climate sectors. Recursive Superintelligence raised over $500M, X Square Robot raised $276M, and Pulnovo Medical raised $100M, with other rounds totaling over $400M. The funding reflects investor interest in AI systems operating in physical environments and applied AI in healthcare workflows.TechStartupsUber deepens bet on Delivery Hero in $318M deal amid EU merger pressure on ProsusUber agreed to buy an additional 4.5% stake in Delivery Hero from Prosus for about €270 million, paying €20 per share. The deal reduces Prosus's stake to roughly 21% and is tied to EU approval of its €4.1 billion Just Eat acquisition. Uber's growing stake signals confidence in Delivery Hero's scale model amid shifting European merger rules.